Larimar Therapeutics Inc (NASDAQ: LRMR) on Monday, plunged -3.78% from the previous trading day, before settling in for the closing price of $3.44. Within the past 52 weeks, LRMR’s price has moved between $1.61 and $9.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 50.78% over the past five years. The company achieved an average annual earnings per share of -43.50%. With a float of $36.46 million, this company’s outstanding shares have now reached $64.03 million.
Let’s look at the performance matrix of the company that is accounted for 65 employees. In terms of profitability, gross margin is 33.2%, operating margin of -43711.2%, and the pretax margin is -39514.94%.
Larimar Therapeutics Inc (LRMR) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Larimar Therapeutics Inc is 43.06%, while institutional ownership is 62.54%. The most recent insider transaction that took place on Jul 31 ’25, was worth 30,000,000. In this transaction Director of this company bought 9,375,000 shares at a rate of $3.20, taking the stock ownership to the 9,538,945 shares.
Larimar Therapeutics Inc (LRMR) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -43.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.80% during the next five years compared to 50.78% growth over the previous five years of trading.
Larimar Therapeutics Inc (NASDAQ: LRMR) Trading Performance Indicators
Larimar Therapeutics Inc (LRMR) is currently performing well based on its current performance indicators. A quick ratio of 7.48 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.49, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.85 in one year’s time.
Technical Analysis of Larimar Therapeutics Inc (LRMR)
Larimar Therapeutics Inc (NASDAQ: LRMR) saw its 5-day average volume 2.05 million, a positive change from its year-to-date volume of 1.01 million. As of the previous 9 days, the stock’s Stochastic %D was 25.36%.
During the past 100 days, Larimar Therapeutics Inc’s (LRMR) raw stochastic average was set at 70.83%, which indicates a significant increase from 21.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.30 in the past 14 days, which was higher than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.98, while its 200-day Moving Average is $3.85.
